{
    "clinical_study": {
        "@rank": "159766", 
        "acronym": "TurkNICU-RSV", 
        "arm_group": {
            "arm_group_label": "Hospitalized Respiratory Syncytial Virus Infected Newborns", 
            "description": "All admitted newborns to the neonatal intensive care unit (NICU) will be enrolled in the study"
        }, 
        "brief_summary": {
            "textblock": "The principle purpose of this multicenter trial is to determine the definition, timing and\n      the percentage of nosocomial RSV epidemics throughout Turkey. In addition, secondary purpose\n      of the trial is to determine the prevention strategies of further spread of Respiratory\n      Syncytial Virus (RSV) in the neonatal intensive care unit (NICU)."
        }, 
        "brief_title": "Management of Hospitalized Respiratory Syncytial Virus (RSV) Infected Patients in the Neonatal Intensive Care Unit (NICU) and Control of Epidemics: TurkNICU-RSV Trial", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Respiratory Syncytial Virus Infections", 
            "Infections, Epidemics"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Respiratory Syncytial Virus Infections", 
                "Virus Diseases"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Confirmed RSV infection with either RSV-strip test or polymerase chain reaction\n             (PCR).\n\n          -  Admission to the NICU or hospitalized in the NICU between 1 October 2013 and 01 April\n             2014.\n\n        Exclusion Criteria:\n\n          -  Refused informed consent"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Days", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Hospitalized RSV infected newborn infants in the NICU."
            }
        }, 
        "enrollment": {
            "#text": "1000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 26, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01915394", 
            "org_study_id": "TurkNICU-RSV"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Respiratory Syncytial Virus Infections", 
            "Epidemics", 
            "Neonatal Intensive Care Unit", 
            "Newborn infants"
        ], 
        "lastchanged_date": "August 1, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Ankara", 
                    "country": "Turkey", 
                    "zip": "06100"
                }, 
                "name": "Ankara University School of Medicine, Department of Pediatrics, Division of Neonatology"
            }
        }, 
        "location_countries": {
            "country": "Turkey"
        }, 
        "number_of_groups": "1", 
        "official_title": "Management of Hospitalized Respiratory Syncytial Virus (RSV) Infected Patients in the Neonatal Intensive Care Unit (NICU) and Control of Epidemics; TurkNICU-RSV Study: A Multicentric, Prospective Trial", 
        "overall_contact": {
            "email": "alanserdar@gmail.com", 
            "last_name": "Serdar Alan, MD", 
            "phone": "+905325991259"
        }, 
        "overall_contact_backup": {
            "email": "omererdeve@yahoo.com", 
            "last_name": "Omer Erdeve, MD", 
            "phone": "+905054812151"
        }, 
        "overall_official": {
            "affiliation": "Ankara University School of Medicine", 
            "last_name": "Omer Erdeve, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Turkey: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Hospitalized Respiratory Syncytial Virus infected Newborn in the Neonatal Intensive Care Units, and its relation with possible epidemics.", 
            "safety_issue": "No", 
            "time_frame": "Patients will be followed during hospitalization, with expected average of 3 weeks"
        }, 
        "reference": [
            {
                "PMID": "23692714", 
                "citation": "Oncel MY, Mutlu B, Kavurt S, Ba\u015f AY, Demirel N, Akyol M, Erdeve O, Dilmen U. Respiratory syncytial virus prophylaxis in preterm infants: a cost-effectiveness study from Turkey. Turk J Pediatr. 2012 Jul-Aug;54(4):344-51."
            }, 
            {
                "PMID": "20299133", 
                "citation": "Dizdar EA, Aydemir C, Erdeve O, Sari FN, Oguz S, Uras N, Dilmen U. Respiratory syncytial virus outbreak defined by rapid screening in a neonatal intensive care unit. J Hosp Infect. 2010 Aug;75(4):292-4. doi: 10.1016/j.jhin.2010.01.013. Epub 2010 Mar 17."
            }, 
            {
                "PMID": "22727129", 
                "citation": "Alan S, Okulu E, Kili\u00e7 A, Atasay B, Arsan S. Palivizumab use during respiratory syncytial virus outbreak in the neonatal intensive care unit. J Hosp Infect. 2012 Aug;81(4):292-3. doi: 10.1016/j.jhin.2012.05.011. Epub 2012 Jun 20."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01915394"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ankara University", 
            "investigator_full_name": "Serdar Alan", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "mortality related to RSV infection and epidemics", 
            "measure": "Mortality", 
            "safety_issue": "No", 
            "time_frame": "Patients will be followed during hospitalization, with expected average of 3 weeks"
        }, 
        "source": "Ankara University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ankara University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "August 2013"
    }
}